Summary
In a significant market movement during October 2024, Nuclera was the subject of a vc funding. The transaction achieved a gross valuation of £57,542,213. Leading the round was Michael D. McCreary, Verve Ventures, M&G Catalyst, Uni Power Group, Elevage Medical Technologies, E Ink Holdings, Cambridge Innovation Capital, GK Goh, Patient Square Capital, Jonathan Milner.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Michael D. McCreary
Lead Investor / Acquirer
Verve Ventures
Lead Investor / Acquirer
M&G Catalyst
Lead Investor / Acquirer
Uni Power Group
Lead Investor / Acquirer
Elevage Medical Technologies
Lead Investor / Acquirer
E Ink Holdings
Lead Investor / Acquirer
Cambridge Innovation Capital
Lead Investor / Acquirer
GK Goh
Lead Investor / Acquirer
Patient Square Capital
Lead Investor / Acquirer
Jonathan Milner
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in